‘Abuse-Resistant’ Form of OxyContin May Be Near

09.10.08
Forbes.com

THURSDAY, Sept. 11 (HealthDay News) — Researchers say they’ve developed an “abuse-resistant” formulation of the widely prescribed opioid pain medication OxyContin.

The U.S. Food and Drug Administration has granted Remoxy priority review, meaning that action could come as soon as early December, said Dr. Nadav Friedman, chief operating officer of Pain Therapeutics Inc., which developed Remoxy.

If approval is granted, said Friedman, who is also co-author of two studies being presented this week at the American Academy of Pain Management’s annual meeting, the drug could get on the market “very quickly.”

Pain Therapeutics Inc., based in San Mateo, Calif., funded both studies. More…

PainCareMD